The Role of Chromatin in Adenoviral Vector Function

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2013 Jun 18

PMID 23771241

Citations 11

Authors

Carmen M Wong

Emily R McFall

Joseph K Burns

Robin J Parks

Affiliations

Soon will be listed here.

Abstract

Vectors based on adenovirus (Ad) are one of the most commonly utilized platforms for gene delivery to cells in molecular biology studies and in gene therapy applications. Ad is also the most popular vector system in human clinical gene therapy trials, largely due to its advantageous characteristics such as high cloning capacity (up to 36 kb), ability to infect a wide variety of cell types and tissues, and relative safety due to it remaining episomal in transduced cells. The latest generation of Ad vectors, helper-dependent Ad (hdAd), which are devoid of all viral protein coding sequences, can mediate high-level expression of a transgene for years in a variety of species ranging from rodents to non-human primates. Given the importance of histones and chromatin in modulating gene expression within the host cell, it is not surprising that Ad, a nuclear virus, also utilizes these proteins to protect the genome and modulate virus- or vector-encoded genes. In this review, we will discuss our current understanding of the contribution of chromatin to Ad vector function.

Citing Articles

Role of homologous recombination/recombineering on human adenovirus genome engineering: Not the only but the most competent solution.

Dawson L, Alshawabkeh M, Schroer K, Arakrak F, Ehrhardt A, Zhang W Eng Microbiol. 2024; 4(1):100140.

PMID: 39628785 PMC: 11611009. DOI: 10.1016/j.engmic.2024.100140.

Impacts of Nucleosome Positioning Elements and Pre-Assembled Chromatin States on Expression and Retention of Transgenes.

Kwizera R, Xie J, Nurse N, Yuan C, Kirchmaier A Genes (Basel). 2024; 15(9).

PMID: 39336823 PMC: 11431089. DOI: 10.3390/genes15091232.

The Development of Methods for the Production of New Molecular Vaccines and Appropriate RNA Fragments to Counteract Unwanted Genes: A Pilot Study.

Sainova I, Kolyovska V, Ilieva I, Markova T, Dimitrova-Dikanarova D, Hadjiolova R Vaccines (Basel). 2023; 11(7).

PMID: 37515042 PMC: 10386085. DOI: 10.3390/vaccines11071226.

Utilizing the LoxP-Stop-LoxP System to Control Transgenic ABC-Transporter Expression In Vitro.

Esobi I, Olanrewaju O, Echesabal-Chen J, Stamatikos A Biomolecules. 2022; 12(5).

PMID: 35625607 PMC: 9138957. DOI: 10.3390/biom12050679.

High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy.

Ricobaraza A, Gonzalez-Aparicio M, Mora-Jimenez L, Lumbreras S, Hernandez-Alcoceba R Int J Mol Sci. 2020; 21(10).

PMID: 32455640 PMC: 7279171. DOI: 10.3390/ijms21103643.

References

Karen K, Hearing P . Adenovirus core protein VII protects the viral genome from a DNA damage response at early times after infection. J Virol. 2011; 85(9):4135-42. PMC: 3126275. DOI: 10.1128/JVI.02540-10. View

Reddy V, Natchiar S, Stewart P, Nemerow G . Crystal structure of human adenovirus at 3.5 A resolution. Science. 2010; 329(5995):1071-5. PMC: 2929978. DOI: 10.1126/science.1187292. View

Smith C, Hager G . Transcriptional regulation of mammalian genes in vivo. A tale of two templates. J Biol Chem. 1997; 272(44):27493-6. DOI: 10.1074/jbc.272.44.27493. View

Brunetti-Pierri N, Nichols T, McCorquodale S, Merricks E, Palmer D, Beaudet A . Sustained phenotypic correction of canine hemophilia B after systemic administration of helper-dependent adenoviral vector. Hum Gene Ther. 2005; 16(7):811-20. DOI: 10.1089/hum.2005.16.811. View

Everitt E, Sundquist B, Pettersson U, Philipson L . Structural proteins of adenoviruses. X. Isolation and topography of low molecular weight antigens from the virion of adenovirus type 2. Virology. 1973; 52(1):130-47. DOI: 10.1016/0042-6822(73)90404-2. View

Perez-Berna A, Marabini R, Scheres S, Menendez-Conejero R, Dmitriev I, Curiel D . Structure and uncoating of immature adenovirus. J Mol Biol. 2009; 392(2):547-57. PMC: 2749003. DOI: 10.1016/j.jmb.2009.06.057. View

Smith A, Poulin K, Parks R . DNA genome size affects the stability of the adenovirus virion. J Virol. 2008; 83(4):2025-8. PMC: 2643769. DOI: 10.1128/JVI.01644-08. View

Chatterjee P, Vayda M, Flint S . Identification of proteins and protein domains that contact DNA within adenovirus nucleoprotein cores by ultraviolet light crosslinking of oligonucleotides 32P-labelled in vivo. J Mol Biol. 1986; 188(1):23-37. DOI: 10.1016/0022-2836(86)90477-8. View

Haruki H, Gyurcsik B, Okuwaki M, Nagata K . Ternary complex formation between DNA-adenovirus core protein VII and TAF-Ibeta/SET, an acidic molecular chaperone. FEBS Lett. 2003; 555(3):521-7. DOI: 10.1016/s0014-5793(03)01336-x. View

10.

Tagami H, Ray-Gallet D, Almouzni G, Nakatani Y . Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell. 2004; 116(1):51-61. DOI: 10.1016/s0092-8674(03)01064-x. View

11.

Xue Y, Johnson J, Ornelles D, Lieberman J, Engel D . Adenovirus protein VII functions throughout early phase and interacts with cellular proteins SET and pp32. J Virol. 2005; 79(4):2474-83. PMC: 546597. DOI: 10.1128/JVI.79.4.2474-2483.2005. View

12.

Hassell J, Lukanidin E, Fey G, Sambrook J . The structure and expression of two defective adenovirus 2/simian virus 40 hybrids. J Mol Biol. 1978; 120(2):209-47. DOI: 10.1016/0022-2836(78)90065-7. View

13.

Drane P, Ouararhni K, Depaux A, Shuaib M, Hamiche A . The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev. 2010; 24(12):1253-65. PMC: 2885661. DOI: 10.1101/gad.566910. View

14.

Leopold P, Ferris B, Grinberg I, Worgall S, Hackett N, Crystal R . Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum Gene Ther. 1998; 9(3):367-78. DOI: 10.1089/hum.1998.9.3-367. View

15.

Cerullo V, Seiler M, Mane V, Brunetti-Pierri N, Clarke C, Bertin T . Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. Mol Ther. 2007; 15(2):378-85. DOI: 10.1038/sj.mt.6300031. View

16.

Mirza M, Weber J . Structure of adenovirus chromatin. Biochim Biophys Acta. 1982; 696(1):76-86. DOI: 10.1016/0167-4781(82)90012-4. View

17.

Okuwaki M, Iwamatsu A, Tsujimoto M, Nagata K . Identification of nucleophosmin/B23, an acidic nucleolar protein, as a stimulatory factor for in vitro replication of adenovirus DNA complexed with viral basic core proteins. J Mol Biol. 2001; 311(1):41-55. DOI: 10.1006/jmbi.2001.4812. View

18.

Ullman A, Hearing P . Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein. J Virol. 2008; 82(15):7325-35. PMC: 2493301. DOI: 10.1128/JVI.00723-08. View

19.

Rauschhuber C, Noske N, Ehrhardt A . New insights into stability of recombinant adenovirus vector genomes in mammalian cells. Eur J Cell Biol. 2011; 91(1):2-9. DOI: 10.1016/j.ejcb.2011.01.006. View

20.

Kawase H, Okuwaki M, Miyaji M, Ohba R, Handa H, Ishimi Y . NAP-I is a functional homologue of TAF-I that is required for replication and transcription of the adenovirus genome in a chromatin-like structure. Genes Cells. 1996; 1(12):1045-56. DOI: 10.1046/j.1365-2443.1996.d01-223.x. View